9XE-50513-96094 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-11
Dose 1 — Pfizer-BioNTech
2021-01-19
Registered in v-safe
2021-02-01
Dose 2 — Pfizer-BioNTech
2021-02-03
Survey response — days 1–6 daily, dose 2
MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Survey response — days 1–6 daily, dose 2
MedDRA: Rhinorrhoea — Feeling: Good · Headache

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-22
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-09-29
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-10-06
Dose 4 — Pfizer-BioNTech
2022-10-10
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-11	Pfizer-BioNTech
2	2021-02-01	Pfizer-BioNTech
3	2021-09-29	Pfizer-BioNTech	Flu
4	2022-10-06	Pfizer-BioNTech	No

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Runny nose

2021-02-07

Systemic reaction (other): Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release